Literature DB >> 21145852

Methylation profile as a new tool for classification of hepatocellular carcinoma.

Christine Perret.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21145852     DOI： 10.1016/j.jhep.2010.10.015

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

1.  Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study.

Authors:  Hui-Chen Wu; Qiao Wang; Hwai-I Yang; Wei-Yann Tsai; Chien-Jen Chen; Regina M Santella
Journal:  Carcinogenesis       Date:  2012-05-12       Impact factor: 4.944

Review 2.  DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma.

Authors:  Sumadi Lukman Anwar; Ulrich Lehmann
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

3.  Sera DNA Methylation of CDH1, DNMT3b and ESR1 Promoters as Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.

Authors:  Cheng-Yun Dou; Yu-Chen Fan; Chuang-Jie Cao; Yang Yang; Kai Wang
Journal:  Dig Dis Sci       Date:  2015-12-10       Impact factor: 3.199

4.  hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma.

Authors:  Sumadi Lukman Anwar; Till Krech; Britta Hasemeier; Elisa Schipper; Nora Schweitzer; Arndt Vogel; Hans Kreipe; Reena Buurman; Britta Skawran; Ulrich Lehmann
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

5.  Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa.

Authors:  Issoufou Tao; Cyrille Bisseye; Bolni Marius Nagalo; Mahamoudou Sanou; Alice Kiba; Guzin Surat; Tegwindé Rebeca Compaoré; Lassina Traoré; Jean Baptiste Nikiema; Virginio Pietra; Jean-Didier Zongo; Jacques Simpore
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.